Drug · DIN 02420295
JAMP-VANCOMYCIN
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since July 29, 2021; first marketed September 22, 2014.
- Drug Identification Number (DIN)
- 02420295
- Company (DIN owner)
- JAMP Pharma CorporationBoucherville, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Powder For Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Vancomycin J01XA01
- Class
- Human
- Record last updated
- June 23, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| VANCOMYCIN (VANCOMYCIN HYDROCHLORIDE) | 500 MG | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 20, 2014: NOC 15296Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies
Other DINs named JAMP-VANCOMYCIN
- DIN 02420309 · Cancelled Post Market